<DOC>
	<DOCNO>NCT01712230</DOCNO>
	<brief_summary>This study design determine whether reduction hormone ( occurs menopause ) cause decrease calorie burn physical activity . This study also determine whether reduction hormone decrease calorie burn sleep , rest , eat whether exercise intervention prevent .</brief_summary>
	<brief_title>Females , Aging , Metabolism , Exercise</brief_title>
	<detailed_description>Participants woman near menopause base age ( 42-52 ) normal menstrual cycle . Participants randomize receive monthly injection placebo study drug reduces sex hormone ( GnRH agonist ) 24 week . Women receive GnRH agonist randomize exercise supervise exercise program . Thus , 3 treatment group : placebo , GnRH agonist , GnRH agonist+exercise . The investigator measure change calorie burn physical activity , sleep , rest , meal 3 6 month hormone suppression use doubly-labeled water room calorimetry . Other measure include food intake estimate food record ; body composition measure dual-energy x-ray absorptiometry ( DXA ) ; glucose insulin response oral glucose tolerance test ; marker inflammation blood .</detailed_description>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Volunteers healthy woman age 40 60 year still experience regular menstrual cycle . They must willing randomized placebo GnRHAG therapy 24 week physically able randomized participate program exercise training program . We consent 132 subject aim enrol 22 3 group ( placebo , GnRHAG , GnRHAG+Exercise ) . irregular menstrual cycle define 2 missed cycle previous year serum FSH &gt; 25 mIU/mL measure first 5 day menstrual cycle hormonal contraceptive menopausal therapy positive pregnancy test intention become pregnant start hormonal contraceptive therapy period study lactation know hypersensitivity GnRH leuprolide acetate score &gt; 16 CESD ( ( Center Epidemiologic Studies Depression Scale ) severe osteopenia osteoporosis ( i.e. , proximal femur lumbar spine score &lt; 2.0 ) abnormal vaginal bleeding thyroid dysfunction , define ultrasensitive TSH &lt; 0.5 &gt; 5.0 mU/L ; volunteer abnormal TSH value reconsider participation study followup evaluation PCP initiation adjustment thyroid hormone replacement uncontrolled hypertension define rest systolic BP &gt; 150 mmHg diastolic BP &gt; 90 mmHg ; participant meet criterion first screen reevaluate , include followup evaluation PCP initiation adjustment antihypertensive medication cardiovascular disease ; subjective objective indicator ischemic heart disease ( e.g. , angina , ST segment depression ) serious arrhythmias rest grade exercise test ( GXT ) without followup evaluation ; followup evaluation must include diagnostic testing ( e.g. , thallium stress test ) interpretation cardiologist orthopedic problem would interfere participation exercise program exercise least 30 minute per day moderate vigorous intensity day week ( define &gt; 4 d/wk ) past 6 month BMI &lt; 40 kg/m2</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>hormone therapy</keyword>
	<keyword>obesity</keyword>
	<keyword>menopause</keyword>
	<keyword>disease /disorder proneness /risk</keyword>
	<keyword>insulin sensitivity /resistance</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>woman 's health</keyword>
</DOC>